Results 1 to 10 of about 21,736 (211)

Pharmaco-EEG-Based Classification of Psychotropic Activity of a Novel Chromone-Containing Allylmorpholine in Rats. [PDF]

Adv Pharm Bull
Sysoev YI, Kurmazov NS, Shitc DD, Puchik MM, Fedorova EV, Petrov NV, Chernov NM, Chervonetskiy SA, Okovityi SV.   +8 more
europepmc   +1 more source

Structure-guided discovery of non-catechol dopamine D1 receptor ligands with biased agonism and antagonism. [PDF]

J Biol Chem
Zhou Y, Wetsel WC, Kahsai AW, Olson SH, Barak LS.   +4 more
europepmc   +1 more source

Using cocaine and apomorphine self-administration in rats to measure the pharmacokinetics of competitive dopamine receptor antagonists administered by different routes. [PDF]

Sci Rep
Song HJ, Desai JN, Norman MK, Norman AB.
europepmc   +1 more source

[Continuous Subcutaneous Apomorphine Infusion Therapy: Economic Impact in Spain]. [PDF]

Rev Neurol
Micolta-Córdoba L, Castro-Ramirez JP, Reyes-Ortiz C.   +2 more
europepmc   +1 more source

Isotopically enriched ⁶⁴ZN-aspartate attenuates systemic inflammation and gut dysbiosis in an LPS-induced rat model of Parkinson's disease. [PDF]

Sci Rep
Temnik M, Rudyk M, Balakin A, Gurin S, Dovbynchuk T, Byshovets R, Dzubenko N, Dovhyi R, Serhiichuk T, Tolstanova G, Skivka L.   +10 more
europepmc   +1 more source

pH-Sensitive Dextrin-Based Nanosponges Crosslinked with Pyromellitic Dianhydride and Citric Acid: Swelling, Rheological Behavior, Mucoadhesion, and In Vitro Drug Release. [PDF]

Gels
Hoti G, Er-Rahmani S, Gatti A, Hussein I, Argenziano M, Cavalli R, Anceschi A, Matencio A, Trotta F, Caldera F.   +9 more
europepmc   +1 more source

Apomorphine-induced disruption of paced mating behavior in female rats is attenuated by eticlopride, a D2 receptor antagonist, but not SCH 23390, a D1 receptor antagonist. [PDF]

Horm Behav
Kong AAH, Beasley TR, Munson HJF, Meerts SH.   +3 more
europepmc   +1 more source

Subcutaneous Foslevodopa as Rescue Therapy for Abrupt Interruption of Oral Dopaminergic Treatment in Parkinson's Disease. [PDF]

Mov Disord Clin Pract
Ory-Magne F, Houeto JL, Fabbri M.
europepmc   +1 more source

The novel GLP-1/GIP dual receptor agonist DA5-CH is superior to tirzepatide and exendin-4 in the 6-OHDA Parkinson rat model. [PDF]

Front Endocrinol (Lausanne)
Lingyu Z, Peng F, Wanting Z, Qianqian J, Zhang Z, Bai B, Xue G, Hölscher C.   +7 more
europepmc   +1 more source

Effect of lumbrokinase on a rat model of hyperlipidemia-induced erectile dysfunction. [PDF]

Transl Androl Urol
Li X, Sun Y, Zhang X, Zhang Z, Han Z, Chen Y.   +5 more
europepmc   +1 more source